Published online January 3, 2005
PEDIATRICS Vol. 115 No. 1 January 2005, pp. 95-101 (doi:10.1542/peds.2004-0516)

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (35) Citing Articles via Google Scholar Google Scholar Articles by Khoshnood, B. Articles by Goffinet, F. Search for Related Content PubMed PubMed Citation Articles by Khoshnood, B. Articles by Goffinet, F. Related Collections Premature & Newborn Social Bookmarking                         What's this?

Trends in Prenatal Diagnosis, Pregnancy Termination, and Perinatal Mortality of Newborns With Congenital Heart Disease in France, 1983–2000: A Population-Based Evaluation

Babak Khoshnood, MD, PhD^*, Catherine De Vigan, MD^*, Véronique Vodovar, RN^*, Janine Goujard, MD^*, Anne Lhomme, MS^*, Damien Bonnet, MD and François Goffinet, MD, MPH^*

^* Paris Registry of Congenital Malformations, Epidemiological Research Unit on Perinatal and Women's Health, INSERM U149, Villejuif, France
Service de Cardiologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France

Objective. To examine population-based overall and malformation-specific trends in the prenatal diagnosis, pregnancy termination, and perinatal mortality for congenital heart disease (CHD) during a period of rapid progress in prenatal diagnosis and medical management of CHD and to explore the impact of prenatal diagnosis on early neonatal mortality for specific (isolated) cardiac malformations.

Methods. A total of 1982 cases of CHD, which were not associated with a known chromosomal anomaly, were obtained from the Paris Registry of Congenital Malformations. Main outcome measures were trends in the proportions diagnosed and terminated before birth, stillbirth, and early (<1 day, 1-week) neonatal mortality for (1) all cases; (2) all cases excluding isolated ventricular septal defects; and (3) malformation-specific trends for transposition of great arteries, hypoplastic left heart syndrome, coarctation of aorta, and tetralogy of Fallot. Analyses included cusum and binomial regression models for analysis of the trends during 1983–2000.

Results. Prenatal diagnosis rates for CHD increased from 23.0% (95% confidence interval [CI]: 19.0–27.4) in 1983–1988 to 47.3% (95% CI: 43.8–50.8) in 1995–2000. Termination rates increased between 1983 and 1989 (9.9%; 95% CI: 7.2–13.2) and 1989 and 1994 (14.7%; 95% CI: 12.3–17.4) but seemed to remain stable thereafter. Other than for hypoplastic left heart syndrome, pregnancy termination was exceptional for the other 3 specific malformations examined. Early neonatal mortality decreased to less than one third in the period 1995–2000 as compared with 1983–1989 (risk ratio, first-week mortality: 0.31; 95% CI: 0.18–0.53). First-week mortality was significantly lower for cases of transposition of great arteries that were diagnosed before birth (risk difference: 15.4%; 95% CI: 4.0–26.7).

Conclusions. Progress in clinical management, together with policies for increased access to prenatal diagnosis, has resulted in both a substantial increase in the prenatal diagnosis and considerable reductions in early neonatal mortality of CHD in the Parisian population.

---

Key Words: congenital heart disease • prenatal diagnosis • France • mortality

Abbreviations: CHD, congenital heart disease • HLHS, hypoplastic left heart syndrome • TGA, transposition of great arteries • ICD-9, International Classification of Disease, Ninth Revision • CI, confidence interval • RR, risk ratio

---

Accepted Jun 21, 2004.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. S. Sklansky, D. P. Berman, J. D. Pruetz, and R.-K. R. Chang Prenatal Screening for Major Congenital Heart Disease: Superiority of Outflow Tracts Over the 4-Chamber View J. Ultrasound Med., July 1, 2009; 28(7): 889 - 899. [Abstract] [Full Text] [PDF]

				J. L. M. McCoyd "I'm not a saint": Burden Assessment as an Unrecognized Factor in Prenatal Decision Making Qual Health Res, November 1, 2008; 18(11): 1489 - 1500. [Abstract] [PDF]

				J. Skinner, T. Hornung, and E. Rumball Transposition of the great arteries: from fetus to adult Heart, September 1, 2008; 94(9): 1227 - 1235. [Full Text] [PDF]

				F. Kaguelidou, L. Fermont, Y. Boudjemline, J. Le Bidois, A. Batisse, and D. Bonnet Foetal echocardiographic assessment of tetralogy of Fallot and post-natal outcome Eur. Heart J., June 1, 2008; 29(11): 1432 - 1438. [Abstract] [Full Text] [PDF]

				S V Rasiah, A K Ewer, P Miller, J G Wright, D J Barron, W J Brawn, and M D Kilby Antenatal perspective of hypoplastic left heart syndrome: 5 years on Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2008; 93(3): F192 - F197. [Abstract] [Full Text] [PDF]

				J. Davis and J J R. Fernando Successful management of prenatal hydrops fetalis in a mother with HIV Int J STD AIDS, April 1, 2008; 19(4): 281 - 282. [Abstract] [Full Text] [PDF]

				B. Khoshnood, C. De Vigan, V. Vodovar, G. Breart, F. Goffinet, and B. Blondel Advances in Medical Technology and Creation of Disparities: The Case of Down Syndrome Am J Public Health, December 1, 2006; 96(12): 2139 - 2144. [Abstract] [Full Text] [PDF]

				M. C M Macintosh, K. M Fleming, J. A Bailey, P. Doyle, J. Modder, D. Acolet, S. Golightly, and A. Miller Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study BMJ, July 22, 2006; 333(7560): 177. [Abstract] [Full Text] [PDF]